Results 91 to 100 of about 339,162 (300)

Phenotypic Identification of Blood Groups in Blood Donors: A Peruvian Multicenter Analysis

open access: yesJournal of Blood Medicine
Cleofe del Pilar Yovera-Ancajima,1,2 Luis Yuri Calderon Cumpa,1,3 Irene Doraliza Lezama-Cotrina,1,4 Eder Walttuoni-Picón,1 Wilmer William Cárdenas-Mendoza,1,5 Jennie Evelyn Culqui-García,1 Wilmer Raul Retuerto-Salazar,1 Roberto Carlos Céspedes Poma1,6 ...
Yovera-Ancajima CDP   +7 more
doaj  

Innate Immune Reprogramming Mediated by Endogenous Retroelement Dysregulation Drives Multiple Sclerosis Progression

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao   +6 more
wiley   +1 more source

Blood typing of feline AB blood group antigens in a random population.

open access: yes, 2016
Blood typing of feline AB blood group antigens in a random population.
Shigenori Ikemoto (3226944)   +18 more
core   +1 more source

Production of soluble recombinant complement receptor (CR1) antigens to detect or inhibit antibodies to Knops (KN) blood group system antigens [PDF]

open access: yes
The purpose of this study was to produce a reagent to use in investigation of antibodies directed against the Knops blood group system antigens. A novel reagent based on sr-proteins was produced and used in a new test to inhibit these antibodies ...
Etheridge, Wendy
core  

Blood group and Rhesus antigens among Blood donors attending the Central Blood Bank, Sudan

open access: yes, 2013
Background: It is well known that the Rhesus system remains the second most clinically important blood group system after the ABO. There is no published work regarding the frequency of various Rhesus antigens among Sudanese population.Objectives: In ...
Hussien, SM   +4 more
core   +1 more source

Quantifying the Impact of Ocrelizumab on Paramagnetic Rim Lesions in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Paramagnetic rim lesions (PRLs) are a subset of chronic active multiple sclerosis (MS) lesions marked by iron‐laden microglia and macrophages. Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, suppresses acute MS activity, but its effect on PRLs remains unclear. In a longitudinal study of 29 ocrelizumab‐treated patients with at least
Kimberly H. Markowitz   +9 more
wiley   +1 more source

COVID-19 patients with blood group A have a higher risk of becoming severe cases compared to non-A blood groups

open access: yesFamily Medicine & Primary Care Review, 2022
KETUT SUEGA, NGAKAN KETUT WIRA SUASTIKA
doaj   +1 more source

Incidence of alloimunization in sickle cell disease: experience of a center in São Paulo

open access: yesEinstein (São Paulo), 2011
Objective: To identify the incidence of alloimmunization in sickle cell disease patients, as well as autoantibodies and the phenotypic profile of these patients for the following erythrocyte antigen groups: Rh, Kell, Kidd, Duffy and MNS.
Ricardo Helman   +2 more
doaj   +2 more sources

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich   +19 more
wiley   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy